These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4790575)

  • 1. Microbiological properties of a new cephalosporin, BL-S 339: 7-(phenylacetimidoyl-aminoacetamido)-3-(2-methyl-1,3,4-thiadiazol-5-ylthiomethyl)ceph-3-em-4-carboxylic acid.
    Misiek M; Pursiano TA; Leitner F; Price KE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):40-8. PubMed ID: 4790575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid.
    Buck RE; Leitner F; Price KE
    Antimicrob Agents Chemother; 1972 Jan; 1(1):67-72. PubMed ID: 4670430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F; Misiek M; Pursiano TA; Buck RE; Chisholm DR; DeRegis RG; Tsai YH; Price KE
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity.
    Noto T; Nehashi T; Endo H; Saito M; Matsubara S
    J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kondo M; Kida M; Nakao M; Iwahi T; Nishi T; Noji Y; Takeuchi M; Nozaki Y
    Antimicrob Agents Chemother; 1981 Jan; 19(1):56-65. PubMed ID: 6941742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin.
    Watanakunakorn C; Bannister T; Glotzbecker C
    Antimicrob Agents Chemother; 1975 Mar; 7(3):381-5. PubMed ID: 1137392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N; Aswapokee P; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kida M; Kondo M; Ono H; Takeuchi M; Nishi T
    Antimicrob Agents Chemother; 1978 Oct; 14(4):557-68. PubMed ID: 718154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
    Ries K; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):168-74. PubMed ID: 4790584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.
    Leitner F; Buck RE; Misiek M; Pursiano TA; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):298-305. PubMed ID: 1137381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents.
    Leitner F; Chisholm DR; Tsai YH; Wright GE; Deregis RG; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):306-10. PubMed ID: 1137382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefadroxil, a new broad-spectrum cephalosporin.
    Buck RE; Price KE
    Antimicrob Agents Chemother; 1977 Feb; 11(2):324-30. PubMed ID: 848939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
    Miraglia GJ; Renz KJ; Gadebusch HH
    Antimicrob Agents Chemother; 1973 Feb; 3(2):270-3. PubMed ID: 4790592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic.
    Overturf GD; Ressler RL; Marengo PB; Wilkins J
    Antimicrob Agents Chemother; 1975 Sep; 8(3):305-10. PubMed ID: 1167042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological activity of cefazedone as compared to cefazolin and cephalothin.
    Knothe H
    Arzneimittelforschung; 1979; 29(2a):378-81. PubMed ID: 39575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.